Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pfizer Opioid Marketing Agreement With Chicago Follows Help In Suit Against Other Firms

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer will disclose opioid risks in its promotional activities and will help with public education and disposal efforts; company has provided evidence to Chicago in its litigation against five other opioid manufacturers.


Related Content

Pharma Pricing, Non-Profit Ties Get Increasing Scrutiny From Prosecutors
Acquittal Of Former Warner Chilcott Exec May Make Future Prosecutions More Difficult


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst